BIOMAT Database Logo BIOMAT Database Logo

Anti-GOR to screen HCV-RNA-positive blood donors. 1991

J Watanabe, and C Matumoto, and K Nishioka, and H Yoshizawa

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

J Watanabe, and C Matumoto, and K Nishioka, and H Yoshizawa
Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients.
January 1993, Vox sanguinis,
J Watanabe, and C Matumoto, and K Nishioka, and H Yoshizawa
Detection of HCV core antigen in HCV RNA positive, anti-HCV negative blood donations from Polish blood donors.
February 2001, Transfusion,
J Watanabe, and C Matumoto, and K Nishioka, and H Yoshizawa
Anti-HCV antibodies and HCV RNA in Libyan blood donors.
January 1995, Vox sanguinis,
J Watanabe, and C Matumoto, and K Nishioka, and H Yoshizawa
Kidney transplantation from anti-HCV-positive donors to anti-HCV-positive recipients.
June 1993, Transplantation proceedings,
J Watanabe, and C Matumoto, and K Nishioka, and H Yoshizawa
Product lookback for anti-HCV-positive blood donors.
January 1995, Vox sanguinis,
J Watanabe, and C Matumoto, and K Nishioka, and H Yoshizawa
Anti-HCV, anti-GOR, and autoimmunity.
April 1992, Lancet (London, England),
J Watanabe, and C Matumoto, and K Nishioka, and H Yoshizawa
Anti-HCV, anti-GOR, and autoimmunity.
April 1992, Lancet (London, England),
J Watanabe, and C Matumoto, and K Nishioka, and H Yoshizawa
Anti-HCV, anti-GOR, and autoimmunity.
April 1992, Lancet (London, England),
J Watanabe, and C Matumoto, and K Nishioka, and H Yoshizawa
Detection and quantitation of serum HCV-RNA by branched DNA amplification in anti-HCV positive blood donors.
May 1994, Journal of hepatology,
J Watanabe, and C Matumoto, and K Nishioka, and H Yoshizawa
Look-back of anti-HCV ELISA-positive, HCV-RNA PCR-negative donors and recipients of their blood products.
January 1997, Vox sanguinis,
Copied contents to your clipboard!